Lexpos News

COVID-19 vaccinations NHS England has confirmed via a system letter, the patient cohorts that will be eligible for vaccination in the Autumn 2025 COVID-19 vaccination programme. This follows the advice of the Joint Committee on Vaccination and Immunisation (JCVI) being accepted by the Government. The announced cohorts for the autumn 2025 programme will cover: Adults [...]

The post Autumn/winter 2025-26 Flu & C-19 vac programme timings confirmed appeared first on Community Pharmacy England.

In the autumn of last year, NHS England started a clinical review of the Pharmacy First clinical pathways and patient group directions (PGD), informed by feedback received from pharmacy teams and other stakeholders, including Community Pharmacy England. Three community pharmacists nominated by Community Pharmacy England participated in the working group which advised NHS England on [...]

The post Advance notice: Updated Pharmacy First clinical pathways and PGDs appeared first on Community Pharmacy England.

In the recent CPCF funding settlement, it was agreed that changes would be made to the Pharmacy Contraception Service (PCS) to include drospirenone within the list of contraceptives which can be supplied and to add oral emergency contraception (EC) to the service. These changes to the service necessitate updates to the service specification, the existing [...]

The post Updated PCS service spec and PGDs published ahead of changes later in the year appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video introducing the Pricing Audit Team (PAT). The Pricing Audit Team undertake monthly audit checks to verify the accuracy of NHS pricing across prescriptions and the Margin Survey. For prescription pricing, pharmacy accounts are audited [...]

The post Funding & Reimbursement Shorts: Introduction to Pricing Audit Team appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 July 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Betaxolol 0.25% eye drops 0.25ml unit dose preservative free Betoptic® 0.25% eye drops [...]

The post 3 products re-classified as special containers from July 2025 appeared first on Community Pharmacy England.